Once the objective of insulin therapy—to approximate physiologic pancreatic secretion of the hormone as closely as possible—is appreciated, the logic of using portable insulin infusion systems is obvious. Such systems have demonstrated their value in minimizing blood glucose lability in juvenile diabetics while permitting patients to pursue normal activities with minimal interference.